Occurrence of goitre during lithium treatment.
Of 330 patients given lithium for recurrent manic-depressive disorder 12 developed goitre after treatment periods of five months to two years. All the patients remained clinically euthyroid. Pressure symptoms necessitated subtotal thyroidectomy in two patients. In 9 out of 10 patients with goitre, and in two out of seven without goitre study with radioactive iodine showed abnormal findings in iodine metabolism. Discontinuance of lithium led to disappearance of goitres, while thyroid metabolism returned to normal. Thyroxine or desiccated thyroid produced shrinkage of the gland in spite of continued lithium medication.
Schou
M
M
Amdisen
A
A
Eskjaer Jensen
S
S
Olsen
T
T
D000293:Adolescent; D000328:Adult; D018692:Antimanic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D006042:Goiter / Q000139:chemically induced* / Q000453:epidemiology / Q000378:metabolism; D006801:Humans; D015994:Incidence; D007455:Iodine / Q000378:metabolism; D008094:Lithium / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D013960:Thyroid Function Tests
D018692:Antimanic Agents; D007455:Iodine; D008094:Lithium